J7513 HCPCS code: Daclizumab, parenteral, 25 mg

J7513 is the HCPCS Level II code for daclizumab, parenteral, 25 mg. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met.

Code details

FieldValue
SectionJ codes — Drugs administered other than oral method
Coverage codeD — Special coverage instructions apply
Pricing indicator51 — Drug or biological (priced per ASP/average sales price rules)
BETOS categoryO1E — Other drugs
Added1999-01-01
Last action effective2018-01-01

What changed for J7513

Frequently asked questions

What is HCPCS code J7513?

J7513 is the HCPCS Level II code for daclizumab, parenteral, 25 mg. Short descriptor: "Daclizumab, parenteral".

Does Medicare cover J7513?

Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.

Related J75 codes

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.

All J codes · HCPCS lookup